Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Acurx Pharmaceuticals, Inc. (ACXP)

1.0600 +0.1143 (+12.09%)
At close: November 6 at 4:00:01 PM EST
1.1300 +0.0700 (+6.60%)
Pre-Market: 5:58:43 AM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Assets
7,689.5350 3,857.9630 7,709.1230 9,376.7060
Total Liabilities
2,420.9430 3,242.8420 3,042.4380 2,061.6850
Total Equity
5,268.5920 615.1210 4,666.6850 7,315.0210
Balance Sheet, Supplemental
Total Debt
0 0 0 0
Net Debt
-7,556.1000 -3,706.7130 -7,474.1880 -9,111.7510
Working Capital
5,268.5920 615.1210 4,666.6850 7,315.0210
Invested Capital
5,268.5920 615.1210 4,666.6850 7,315.0210
Tangible Book Value
5,268.5920 615.1210 4,666.6850 7,315.0210
Common Equity Book Value
5,268.5920 615.1210 4,666.6850 7,315.0210
12/31/2022 - 6/25/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: